LAB vs LC · rev $174.4M vs P/E 28, $1.43B cap
Standard Biotools Inc (LAB) versus LendingClub Corp (LC) — a side-by-side from cached financials, not a winner call.
Standard Biotools Inc (LAB) is a medical devices company listed on NASDAQ.
LendingClub Corp (LC) is a banks - regional company listed on US.
Latest reported LAB revenue for 2024-12-31 was $174.4M. Net income was -$138.9M. Revenue was up 64.0% from 2023-12-31 to 2024-12-31. LAB currently screens at market cap $317.1M.
LC does not have a complete income-statement cache yet.
LAB currently screens at market cap $317.1M. LC currently screens at market cap $1.43B and trailing P/E 28.4.
Not investment advice. Open the LAB and LC stock pages for the full models.
Not investment advice.